Document is current
Any future updates will be listed below
-
Authors
Fisher, Elizabeth L. https://orcid.org/0000-0002-9557-9291
Smith, Ryan https://orcid.org/0000-0002-4448-185X
Conn, Kyna
Corcoran, Andrew W. https://orcid.org/0000-0002-0449-4883
Milton, Laura K.
Hohwy, Jakob
Foldi, Claire J. https://orcid.org/0000-0002-3293-8242
-
Funding
Funding for this research was provided by:
Three Springs Foundation Grant
Department of Health | National Health and Medical Research Council (GNT2011334)
- License Information
-
More Information
Article History
Received: 19 May 2024
Revised: 18 September 2024
Accepted: 19 September 2024
First Online: 30 September 2024
Competing interests
: We would like to acknowledge A/Prof Alexxai Kravitz (Washington University in St Louis) for input into task design and operations and the USONA Institute Investigational Drug Supply Program (Madison, WI) for providing the psilocybin used in these studies. We acknowledge the use of Biorender for aspects of the figures. This work was supported by a National Health and Medical Research Council Grant (Grant No. GNT2011334) to CJF and a Three Springs Foundation Grant awarded to JH. CJF sits on the scientific advisory board for Octarine Bio, Denmark. No other authors report biomedical financial interests or potential conflicts of interests.
